News
RGEN
146.92
+0.51%
0.75
Repligen (RGEN) Shares Cross Below 200 DMA
NASDAQ · 2d ago
Repligen (RGEN) Gets a Buy from Craig-Hallum
TipRanks · 2d ago
Is Repligen (NASDAQ:RGEN) A Risky Investment?
Simply Wall St · 2d ago
3 Healthcare Stocks Skating on Thin Ice
Barchart · 2d ago
Repligen started at buy by TD Cowen, limited NIH exposure cited
Seeking Alpha · 4d ago
BUZZ-10x Genomics, Quanterix worst-hit if US health agency cuts costs, Leerink says
Reuters · 4d ago
Amazon downgraded, Shopify upgraded: Wall Street’s top analyst calls
TipRanks · 4d ago
“Top-Tier”Repligen to Outperform Peers Thanks to AI and Low China Exposure
TipRanks · 4d ago
REPLIGEN CORP <RGEN.O>: TD COWEN INITIATES COVERAGE WITH BUY RATING; TARGET PRICE $200
Reuters · 4d ago
Repligen initiated with a Buy at TD Cowen
TipRanks · 4d ago
Weekly Report: what happened at RGEN last week (0203-0207)?
Weekly Report · 4d ago
U.S. RESEARCH ROUNDUP-Amazon, Equifax, Wesbanco
Reuters · 4d ago
Weekly Report: what happened at RGEN last week (0127-0131)?
Weekly Report · 02/03 09:10
HRMY vs. RGEN: Which Stock Is the Better Value Option?
NASDAQ · 01/30 16:40
Repligen (RGEN) Surges 3.7%: Is This an Indication of Further Gains?
NASDAQ · 01/29 08:19
Sartorius lifts U.S. peers after 2024 results
Seeking Alpha · 01/28 12:16
Weekly Report: what happened at RGEN last week (0120-0124)?
Weekly Report · 01/27 09:10
Conestoga Capital Advisors Q4 2024 Quarterly Commentary
Seeking Alpha · 01/26 14:13
REPLIGEN CORP <RGEN.O>: H.C. WAINWRIGHT CUTS TARGET PRICE TO $180 FROM $240
Reuters · 01/23 11:18
Repligen price target lowered to $180 from $240 at H.C. Wainwright
TipRanks · 01/23 11:11
More
Webull provides a variety of real-time RGEN stock news. You can receive the latest news about Repligen through multiple platforms. This information may help you make smarter investment decisions.
About RGEN
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. The Company's bioprocessing business consists of four main franchises: filtration (including fluid management); chromatography; process analytics, and proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. The Company’s chromatography franchise includes a number of products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. The Company’s TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes.